2 results
6-K
TAK
Takeda Pharmaceutical Co
1 Nov 21
Current report (foreign)
6:04am
a climate scenario analysis in fiscal year 2020 of its direct business operations. This initial climate scenario analysis provided important insights
6-K
EX-99.1
TAK
Takeda Pharmaceutical Co
6 Jul 23
Current report (foreign)
6:18am
an investigational product begins clinical trials and conduct scenario analysis. Phase II: Update product report card; develop further mitigation
- Prev
- 1
- Next